Fidelity Investments’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15K Buy
8,895
+1,052
+13% +$1.87K ﹤0.01% 4630
2025
Q4
$11.1K Sell
7,843
-479
-6% -$698 ﹤0.01% 4691
2025
Q3
$13.6K Buy
8,322
+1,830
+28% +$2.04K ﹤0.01% 4508
2025
Q2
$4.75K Sell
6,492
-18,114
-74% -$15.6K ﹤0.01% 4718
2025
Q1
$19.9K Buy
24,606
+288
+1% +$331 ﹤0.01% 4223
2024
Q4
$33.6K Sell
24,318
-200,795
-89% -$225K ﹤0.01% 4018
2024
Q3
$234K Buy
225,113
+39,204
+21% +$53.8K ﹤0.01% 3145
2024
Q2
$322K Buy
185,909
+100,409
+117% +$202K ﹤0.01% 2877
2024
Q1
$204K Sell
85,500
-75,709
-47% -$186K ﹤0.01% 3025
2023
Q4
$537K Buy
161,209
+16,346
+11% +$43.8K ﹤0.01% 2665
2023
Q3
$542K Buy
144,863
+48,359
+50% +$223K ﹤0.01% 2608
2023
Q2
$412K Sell
96,504
-1,531
-2% -$9.03K ﹤0.01% 2717
2023
Q1
$671K Buy
98,035
+28,634
+41% +$222K ﹤0.01% 2611
2022
Q4
$550K Buy
69,401
+23
+0% +$177 ﹤0.01% 2689
2022
Q3
$666K Buy
69,378
+40,049
+137% +$405K ﹤0.01% 2700
2022
Q2
$213K Sell
29,329
-34,855
-54% -$303K ﹤0.01% 3109
2022
Q1
$829K Buy
64,184
+52,681
+458% +$670K ﹤0.01% 2826
2021
Q4
$183K Sell
11,503
-52,630
-82% -$920K ﹤0.01% 2971
2021
Q3
$1.03M Sell
64,133
-1,133
-2% -$16.6K ﹤0.01% 2690
2021
Q2
$902K Sell
65,266
-2,878
-4% -$40.8K ﹤0.01% 2684
2021
Q1
$996K Sell
68,144
-628,648
-90% -$10.7M ﹤0.01% 2583
2020
Q4
$12.1M Sell
696,792
-192,431
-22% -$3.43M ﹤0.01% 1902
2020
Q3
$16.3M Sell
889,223
-207,767
-19% -$3.87M ﹤0.01% 1647
2020
Q2
$19.6M Buy
1,096,990
+102,051
+10% +$1.73M ﹤0.01% 1553
2020
Q1
$16.1M Buy
994,939
+44,138
+5% +$815K ﹤0.01% 1491
2019
Q4
$17.1M Sell
950,801
-2,322,361
-71% -$42.8M ﹤0.01% 1652
2019
Q3
$66.3M Sell
3,273,162
-99,365
-3% -$1.99M 0.01% 1049
2019
Q2
$74.5M Sell
3,372,527
-754,807
-18% -$13.1M 0.01% 1047
2019
Q1
$56.3M Sell
4,127,334
-452,896
-10% -$6.04M 0.01% 1168
2018
Q4
$41.5M Sell
4,580,230
-1,881,614
-29% -$21.8M 0.01% 1222
2018
Q3
$107M Sell
6,461,844
-433,370
-6% -$7.68M 0.01% 920
2018
Q2
$96.5M Sell
6,895,214
-591,923
-8% -$8.47M 0.01% 968
2018
Q1
$82.7M Buy
7,487,137
+802,971
+12% +$8.78M 0.01% 1061
2017
Q4
$58.8M Sell
6,684,166
-1,022,144
-13% -$10.9M 0.01% 1221
2017
Q3
$103M Buy
7,706,310
+13,186
+0.2% +$174K 0.01% 961
2017
Q2
$110M Buy
7,693,124
+21,143
+0.3% +$407K 0.01% 941
2017
Q1
$162M Buy
7,671,981
+1,124,163
+17% +$27.7M 0.02% 783
2016
Q4
$184M Buy
6,547,818
+40,787
+0.6% +$1.14M 0.02% 711
2016
Q3
$174M Buy
6,507,031
+110,803
+2% +$3.02M 0.02% 741
2016
Q2
$108M Buy
6,396,228
+530,715
+9% +$9.96M 0.01% 938
2016
Q1
$125M Buy
5,865,513
+774,708
+15% +$12.7M 0.02% 875
2015
Q4
$117M Buy
5,090,805
+1,336,499
+36% +$34.4M 0.02% 897
2015
Q3
$75.2M Buy
3,754,306
+1,046,277
+39% +$31.8M 0.01% 1080
2015
Q2
$78.3M Buy
2,708,029
+1,873,076
+224% +$47.4M 0.01% 1140
2015
Q1
$25.5M Sell
834,953
-351,900
-30% -$9.09M ﹤0.01% 1641
2014
Q4
$17.3M Buy
+1,186,853
New +$16.7M ﹤0.01% 1795

Other funds holding CHRS